2Kamb A,Gruis NA,Weaver-Feldhaus J,et al.A cell cycle regulator potentially involved in genesis of many tumor types[J].Science,1994,264(5157):436-440.
3Ravdin PM,Chamness GC.The c-erbB-2 proto-oncogene as a prog nostic and predictive marker in breast cancer:a paradigm for the development of other macromolecular markers-a review[J].Gene,1995,159(1):19-27.
4Leitzel K,Teramoto Y,Konrad K,et al.Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer[J].J Clin Oncol,1995,13(5):1129-1135.
5Hynes NE,Stern DF.The biology of erbB-2/neu/HER-2 and its role in cancer[J].Biochim Biophys Acta,1994,1198(2-3):165-184.
6Coussens L,Yang-Feng TL,Liao YC,et al.Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene[J].Science,1985,230(4730):1132-1139.
7Drebin JA,Link VC,Weinberg RA,et al.Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen[J].Proc Natl Acad Sci U S A,1986,83(23):9129-9133.
8Samanta A,LeVea CM,Dougall WC,et al.Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation[J].Proc Natl Acad Sci U S A,1994,91(5):1711-1715.
9Cook DB,Bustamam AA,Brotherick I,et al.Lectin ELISA for the c-erb-B2 tumor marker protein p185 in patients with breast cancer and controls[J].Clin Chem,1999,45(2):292-295.
10Brandt.Rauf PW,Luo JC,Carney WP,et a.Detection of increasedamounts of the extracellular domain of the c-erbB-2 oncoprotein inserum during pulmonary carcinogenesis in humans[J].Int J Caneer,1994,156(3):383-386.
二级参考文献8
1[1]Stenman G, Sandros J, Nordkvist A, et al. Expression of the ERBB-2 Protein in Bengin and Malignant Salivary Gland Tumor[J]. Genes Chromosom Cancer,1991,3(2):128.
2[2]Slamon DJ, Clark GM, Wong SG, et al. Human Breast Cancer: Correlation of Relapse and Survival with the Application of HER-2/neu Oncogene[J]. Science,1987,235:177～182.
3[3]Hynes N E, stem DF. The Biology of ErbB-2/neu/HER-2 and Its Role in Cancer[J]. Biochemica et Biop Hysica Acta,1994,1198:165.
4[4]Ravdin PM, Chamness GC. The c-erbB-2 Proto-oncogene As a Prognostic and Predictive Marker in Breast Caner; A Paradigm for the Development of Other Micromolecmar Marker Review[J]. Gene,1995,159:19.
5[5]Brandt CRauf PW, Luo JC, Carney Wp, et al. Detection of Increased Amounts of the Extracellular Domain of the c-erbB-2 Oncoprotein in Serum during Pulmonary Carcinogenesis in Humans[J]. Int-J-Cancer,1994,156(3):383～386.
6[6]Eitzel K. Elavated Serum c-erbB-2 Antigen Levels and Decreased Response to Hormone Therapy of Breast Cancer[J]. J Clin Oncol,1995,13(5):1129～1135.
7[7]Shigeru I, Hisanao O, Kokichi S, et al. Determination of Cytosol C-erbB2 Protein in Breast Cancer by Sandwich Enzyme Immunoassay[J]. Jpn J Clin,1998,28(2):92.
8H. Shelton Earp,Thomas L. Dawson,Xiong Li,Hong Yu. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research[J] 1995,Breast Cancer Research and Treatment(1):115～132
3Leyland-Jones B, Smith BR. Serum HER2 testing in patients with HER2-positive breast cancer: the death knell tolls. Lancet Oncol, 2011,12 (3) :286-295.
4Leyland-Jones B, Smith BR. Serum HER2 testing in pa- tients with HER2-positive breast cancer: the death knell tolls[J]. Lancet Oncol,2011,12(3) :286-295.
